Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 01-2008 | 12-2007 | 01-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,219 | -3,381 | -18,139 | 565 | -19,399 |
| Depreciation Amortization | 716 | 723 | 436 | 638 | 980 |
| Income taxes - deferred | N/A | -1,984 | N/A | 213 | N/A |
| Accounts receivable | 77 | 567 | -148 | -430 | 3 |
| Accounts payable and accrued liabilities | 1,702 | 1,657 | -138 | -442 | 829 |
| Other Working Capital | 1,637 | -701 | -797 | -283 | 1,871 |
| Other Operating Activity | -1,271 | -1,710 | 3,674 | 929 | 1,969 |
| Operating Cash Flow | $-9,358 | $-4,829 | $-15,112 | $1,190 | $-13,747 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -6,754 | N/A | -18,329 |
| PPE Investments | -73 | -183 | -212 | -323 | -1,351 |
| Net Acquisitions | N/A | -1,000 | N/A | N/A | N/A |
| Sale Of Investment | 3,951 | N/A | 21,132 | N/A | 12,548 |
| Purchase Sale Intangibles | -142 | N/A | -211 | N/A | -73 |
| Other Investing Activity | -142 | 0 | -10,211 | 0 | -73 |
| Investing Cash Flow | $3,736 | $-1,183 | $3,955 | $-323 | $-7,205 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,514 | N/A | N/A | N/A |
| Debt Issued | N/A | 5,920 | N/A | N/A | N/A |
| Debt Repayment | N/A | -2,670 | -4,102 | -230 | N/A |
| Common Stock Issued | 270 | N/A | 11,620 | N/A | 20,771 |
| Common Stock Repurchased | N/A | N/A | N/A | -2,467 | N/A |
| Other Financing Activity | 0 | 0 | 1,374 | 0 | 0 |
| Financing Cash Flow | $270 | $4,764 | $8,892 | $-2,697 | $20,771 |
| Beginning Cash Position | 1,471 | 1,276 | 3,646 | 3,106 | 3,827 |
| End Cash Position | 6,119 | 28 | 11,471 | 1,276 | 3,646 |
| Net Cash Flow | $-5,352 | $-1,248 | $7,825 | $-1,830 | $-181 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,358 | -4,829 | -15,112 | 1,190 | -13,747 |
| Capital Expenditure | -73 | -693 | -212 | -378 | -1,351 |
| Free Cash Flow | -9,431 | -5,522 | -15,324 | 812 | -15,098 |